Interference with HMGB1 increases the sensitivity to chemotherapy drugs by inhibiting HMGB1-mediated cell autophagy and inducing cell apoptosis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interference with HMGB1 increases the sensitivity to chemotherapy drugs by inhibiting HMGB1-mediated cell autophagy and inducing cell apoptosis
Authors
Keywords
High-mobility group protein 1, Autophagy, Apoptosis, Chemotherapy drug, Non-small cell lung cancer
Journal
TUMOR BIOLOGY
Volume 36, Issue 11, Pages 8585-8592
Publisher
Springer Nature
Online
2015-06-04
DOI
10.1007/s13277-015-3617-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Significance of HMGB1 Expression in Human Gastric Cancer
- (2017) J. Zhang et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Expression of MicroRNA-325-3p and its potential functions by targeting HMGB1 in non-small cell lung cancer
- (2015) Shihua Yao et al. BIOMEDICINE & PHARMACOTHERAPY
- HMGB1-mediated autophagy modulates sensitivity of colorectal cancer cells to oxaliplatin via MEK/ERK signaling pathway
- (2015) Weijun Liu et al. CANCER BIOLOGY & THERAPY
- Clinical effectiveness of first-line chemoradiation for adult patients with locally advanced non-small cell lung cancer: a systematic review
- (2014) T Brown et al. HEALTH TECHNOLOGY ASSESSMENT
- Efficacy and safety of angiogenesis inhibitors in advanced non-small cell lung cancer: a systematic review and meta-analysis
- (2014) Shaodong Hong et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- miR-200c inhibits metastasis of breast cancer cells by targeting HMGB1
- (2014) Bao-ping Chang et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- High Mobility Group Box1 (HMGB1) released from cancer cells induces the expression of pro-inflammatory cytokines in peritoneal fibroblasts
- (2014) Anna Abe et al. PATHOLOGY INTERNATIONAL
- HMGB1 promotes cellular proliferation and invasion, suppresses cellular apoptosis in osteosarcoma
- (2014) Qingbing Meng et al. TUMOR BIOLOGY
- MiRNA-218, a new regulator of HMGB1, suppresses cell migration and invasion in non-small cell lung cancer
- (2013) C. Zhang et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Medical treatment of advanced non-small cell lung cancer in elderly patients: A review of the role of chemotherapy and targeted agents
- (2013) Giulia Meoni et al. Journal of Geriatric Oncology
- RETRACTED: High-mobility group protein B1 (HMGB1) is a novel biomarker for human ovarian cancer
- (2012) Jie Chen et al. GYNECOLOGIC ONCOLOGY
- Clinical and economic review of erlotinib in non-small-cell lung cancer
- (2012) Kai Yeung et al. Expert Review of Pharmacoeconomics & Outcomes Research
- HMGB1 Promotes Drug Resistance in Osteosarcoma
- (2011) J. Huang et al. CANCER RESEARCH
- Review of the incidence, prevalence, mortality and causative factors for lung cancer in Europe
- (2011) Stephen J. O'Connor EUROPEAN JOURNAL OF CANCER
- HMG modifications and nuclear function
- (2010) Qingchun Zhang et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- The HMGB protein gene family in zebrafish: Evolution and embryonic expression patterns
- (2010) Silvia Moleri et al. GENE EXPRESSION PATTERNS
- Nuclear functions of the HMG proteins
- (2009) Raymond Reeves Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Critical Review of Nonsurgical Treatment Options for Stage I Non-Small Cell Lung Cancer
- (2008) C. J.A. Haasbeek et al. ONCOLOGIST
- Chromosomal high mobility group (HMG) proteins of the HMGB-type occurring in the moss Physcomitrella patens
- (2007) Bruno Kiilerich et al. GENE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started